Insect cells as factories for biomanufacturing

Area of Science:

• Biotechnology
• Cell Biology
• Molecular Biology

Background:

• Insect cells (IC), particularly lepidopteran cells, present a viable alternative to mammalian cells for biomanufacturing.
• The baculovirus expression vector system (BEVS) combined with insect cells (IC-BEVS) provides a potent platform for producing diverse heterologous gene products.
• IC-BEVS facilitates large-scale manufacturing through integrated cell growth and recombinant baculovirus infection processes.

Purpose of the Study:

• To review current knowledge on insect cell metabolism, culture conditions, and applications in biomanufacturing.
• To highlight the potential of IC-BEVS for producing proteins, vaccines, and gene therapy vectors.
• To discuss the advantages of insect cells, including functional multimeric protein production and cultivation in serum-free media.

Main Methods:

• Literature review of insect cell metabolism, culture conditions, and applications.
• Analysis of the IC-BEVS platform for heterologous gene product formation.
• Examination of large-scale production processes and product applications.

Main Results:

• Insect cells can produce functionally equivalent multimeric proteins and engineered vectors for efficient expression.
• Insect cells can be readily cultured in serum- and protein-free media, simplifying downstream processing.
• Numerous IC-BEVS-derived products are in clinical trials or on the market for human and veterinary use.

Conclusions:

• The IC-BEVS platform is a powerful and scalable technology for biomanufacturing diverse therapeutic products.
• Insect cells offer advantages in protein production and ease of cultivation, driving commercial interest.
• Continued research into insect cell metabolism and culture optimization will further enhance biomanufacturing capabilities.